FOSTER CITY, Calif. -- Sept. 29, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Mike Grey will be speaking on a panel, Driving Life Sciences Discovery in 2011 and Beyond: Acquire or Partner? at BIOCOMS May breakfast meeting, San Diego CA.
News | 05. 04. 2011
